Mira Pharmaceuticals, Common Stock Shares Outstanding
| MIRA Stock | 1.21 0.01 0.83% |
MIRA Pharmaceuticals, Common fundamentals help investors to digest information that contributes to MIRA Pharmaceuticals,'s financial success or failures. It also enables traders to predict the movement of MIRA Stock. The fundamental analysis module provides a way to measure MIRA Pharmaceuticals,'s intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to MIRA Pharmaceuticals, stock.
As of January 18, 2025, Common Stock Shares Outstanding is expected to decline to about 17.3 M. MIRA | Shares Outstanding |
MIRA Pharmaceuticals, Common Company Shares Outstanding Analysis
MIRA Pharmaceuticals,'s Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current MIRA Pharmaceuticals, Shares Outstanding | 16.56 M |
Most of MIRA Pharmaceuticals,'s fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, MIRA Pharmaceuticals, Common is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
MIRA Shares Outstanding Driver Correlations
Understanding the fundamental principles of building solid financial models for MIRA Pharmaceuticals, is extremely important. It helps to project a fair market value of MIRA Stock properly, considering its historical fundamentals such as Shares Outstanding. Since MIRA Pharmaceuticals,'s main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of MIRA Pharmaceuticals,'s historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of MIRA Pharmaceuticals,'s interrelated accounts and indicators.
Click cells to compare fundamentals
MIRA Shares Outstanding Historical Pattern
Today, most investors in MIRA Pharmaceuticals, Stock are looking for potential investment opportunities by analyzing not only static indicators but also various MIRA Pharmaceuticals,'s growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's shares outstanding growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of MIRA Pharmaceuticals, shares outstanding as a starting point in their analysis.
MIRA Pharmaceuticals, Shares Outstanding |
| Timeline |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
MIRA Common Stock Shares Outstanding
Common Stock Shares Outstanding |
|
Based on the latest financial disclosure, MIRA Pharmaceuticals, Common has 16.56 M of shares currently outstending. This is 90.83% lower than that of the Pharmaceuticals sector and 84.5% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 97.1% higher than that of the company.
MIRA Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses MIRA Pharmaceuticals,'s direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of MIRA Pharmaceuticals, could also be used in its relative valuation, which is a method of valuing MIRA Pharmaceuticals, by comparing valuation metrics of similar companies.MIRA Pharmaceuticals, is currently under evaluation in shares outstanding category among its peers.
MIRA Fundamentals
| Return On Equity | -7.49 | ||||
| Return On Asset | -1.78 | ||||
| Current Valuation | 16.51 M | ||||
| Shares Outstanding | 16.56 M | ||||
| Shares Owned By Insiders | 27.20 % | ||||
| Shares Owned By Institutions | 5.95 % | ||||
| Number Of Shares Shorted | 594.12 K | ||||
| Price To Book | 5.61 X | ||||
| EBITDA | (3.46 M) | ||||
| Net Income | (11.98 K) | ||||
| Total Debt | 5.06 K | ||||
| Book Value Per Share | 0.30 X | ||||
| Cash Flow From Operations | (5.63 M) | ||||
| Short Ratio | 0.47 X | ||||
| Earnings Per Share | (0.55) X | ||||
| Target Price | 12.08 | ||||
| Market Capitalization | 20.04 M | ||||
| Total Asset | 4.93 M | ||||
| Retained Earnings | (21.29 M) | ||||
| Working Capital | (875.63 K) | ||||
| Net Asset | 4.93 M |
About MIRA Pharmaceuticals, Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze MIRA Pharmaceuticals, Common's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MIRA Pharmaceuticals, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MIRA Pharmaceuticals, Common based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin |
Check out MIRA Pharmaceuticals, Piotroski F Score and MIRA Pharmaceuticals, Altman Z Score analysis. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MIRA Pharmaceuticals,. If investors know MIRA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MIRA Pharmaceuticals, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of MIRA Pharmaceuticals, is measured differently than its book value, which is the value of MIRA that is recorded on the company's balance sheet. Investors also form their own opinion of MIRA Pharmaceuticals,'s value that differs from its market value or its book value, called intrinsic value, which is MIRA Pharmaceuticals,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MIRA Pharmaceuticals,'s market value can be influenced by many factors that don't directly affect MIRA Pharmaceuticals,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MIRA Pharmaceuticals,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if MIRA Pharmaceuticals, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MIRA Pharmaceuticals,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.